Table 2.

Comparison of endpoints at six weeks expressed as changes from baseline.

	Treatment	Placebo	P value
Total Cholesterol (mmol/L)	-0.3 ± 0.1 ***	-0.1 ± 0.08	0.184
LDL cholesterol (mmol/L)**	-0.3 ± 0.1 ***	-0.04 ± 0.08	0.026
HDL cholesterol (mmol/L)	-0.02 ± 0.02	-0.009 ± 0.02	0.842
Triglyceride (mmol/L)*	0.09 ± 0.1	-0.2 ± 0.1***	0.030
Cholesterol/HDL ratio	-0.2 ± 0.1	-0.1 ± 0.1	0.947
C-Reactive protein (mg/dL)	-0.03 ± 0.06	0.01 ± 0.04	0.546
Homocysteine (μM/L)	0.4 ± 0.4	0.2 ± 0.2	0.528
Insulin (pmol/L)	6.9 ± 4.9	4.2 ± 10.4	0.804
Glucose (mmol/L)	0.2 ± 0.09	0.03 ± 0.09	0.259
Weight (kg)	-0.7 ± 0.3	1.4 ± 1.3	0.117
Blood pressure (systolic/diastolic, mmHg, value at end point)	119/69 ± 1.9/1.3	119/69 ± 2.0/1.7	0.832/0.856
Total Energy Intake per day (kJ)	-519 ± 330	-343 ± 360	0.724
Carbohydrate intake (% of total)	0.4 ± 2.0	1.8 ± 1.3	0.535
Protein Intake (% of total)	0.9 ± 0.6	-0.9 ± 1.1	0.041
Fat Intake (% of total)	-0.7 ± 1.8	-1.2 ± 1.1	0.784
Dietary Fiber Intake (grams)	-0.3 ± 1.1	-1.4 ± 1.6	0.454

Data are means ± SEM.

***Statistically different from baseline, within group comparison p < 0.05